Brief: Cytomx Therapeutics Provides Business Update And Outlines 2023 Company Priorities
05/01/2023 21:55
Jan 5 (Reuters) - CytomX Therapeutics Inc CTMX.O :
* CYTOMX THERAPEUTICS PROVIDES BUSINESS UPDATE AND
OUTLINES 2023
COMPANY PRIORITIES
* CYTOMX THERAPEUTICS INC - ALSO REMAINS IN A STRONG
FINANCIAL
POSITION WITH CASH INTO 2025
* CYTOMX THERAPEUTICS INC - SEES FILING OF TWO INDS FOR NEXT
GENERATION WHOLLY OWNED PROGRAMS IN 2023
* CYTOMX THERAPEUTICS INC - DETERMINE NEXT STEPS WITH ABBVIE
FOR
CX-2029 (CD71) IN 2023
Source text for Eikon: ID:nGNX8R3F42
Further company coverage: CTMX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on CytomX Therapeutics
See all newsCytomX Q2 revenue misses, partly hurt by lower research activities in the Astellas collaboration
CytomX Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Cytomx Therapeutics Announces Appointment Of Charles Fuchs, M.D., M.P.H., To The Board Of Directors
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway